Series B funding from MedVenture Partners and DBJ Capital
- Author: admin_epmed
- Category: NEWS
We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and DBJ Capital Co., Ltd.
We will continue to develop intravascular EEG measurement devices.
Related posts
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our Endovascular EEG device (EP-01).
We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…
- Category: NEWS
AMED grant recipient
Fiscal Year 2021「Medical and Engineering Collaboration Innovation Promotion Project (Development and Commercialization Project)」About the selected projects
- Category: NEWS
E.P. Medical website launched
In November 2021, the E.P. Medical website was launched.
- Category: NEWS
Certified as a venture company originating from the University of Tsukuba
Our company has been certified as a venture company spun out of the University of Tsukuba. University of Tsukuba
- Category: NEWS